Matches in Wikidata for { <http://www.wikidata.org/entity/Q91283841> ?p ?o ?g. }
- Q91283841 description "2019 nî lūn-bûn" @default.
- Q91283841 description "2019年の論文" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年学术文章" @default.
- Q91283841 description "2019年學術文章" @default.
- Q91283841 description "2019年學術文章" @default.
- Q91283841 description "2019年學術文章" @default.
- Q91283841 description "2019年學術文章" @default.
- Q91283841 description "2019年學術文章" @default.
- Q91283841 description "2019년 논문" @default.
- Q91283841 description "article científic" @default.
- Q91283841 description "article scientific" @default.
- Q91283841 description "article scientifique" @default.
- Q91283841 description "articol științific" @default.
- Q91283841 description "articolo scientifico" @default.
- Q91283841 description "artigo científico" @default.
- Q91283841 description "artigo científico" @default.
- Q91283841 description "artigo científico" @default.
- Q91283841 description "artikel ilmiah" @default.
- Q91283841 description "artikull shkencor" @default.
- Q91283841 description "artikulong pang-agham" @default.
- Q91283841 description "artykuł naukowy" @default.
- Q91283841 description "artículo científico publicado en 2019" @default.
- Q91283841 description "artículu científicu" @default.
- Q91283841 description "bilimsel makale" @default.
- Q91283841 description "bài báo khoa học" @default.
- Q91283841 description "naučni članak" @default.
- Q91283841 description "scienca artikolo" @default.
- Q91283841 description "scientific article published on 14 November 2019" @default.
- Q91283841 description "scientific article published on 14 November 2019" @default.
- Q91283841 description "scientific article published on 14 November 2019" @default.
- Q91283841 description "teaduslik artikkel" @default.
- Q91283841 description "tieteellinen artikkeli" @default.
- Q91283841 description "tudományos cikk" @default.
- Q91283841 description "vedecký článok" @default.
- Q91283841 description "vetenskaplig artikel" @default.
- Q91283841 description "videnskabelig artikel udgivet 14. november 2019" @default.
- Q91283841 description "vitenskapelig artikkel" @default.
- Q91283841 description "vitskapeleg artikkel" @default.
- Q91283841 description "vědecký článek" @default.
- Q91283841 description "wetenschappelijk artikel" @default.
- Q91283841 description "wissenschaftlicher Artikel" @default.
- Q91283841 description "επιστημονικό άρθρο" @default.
- Q91283841 description "мақолаи илмӣ" @default.
- Q91283841 description "наукова стаття, опублікована в листопаді 2019" @default.
- Q91283841 description "научна статия" @default.
- Q91283841 description "научная статья" @default.
- Q91283841 description "научни чланак" @default.
- Q91283841 description "научни чланак" @default.
- Q91283841 description "գիտական հոդված հրատարակված 2019 թվականի նոյեմբերի 14-ին" @default.
- Q91283841 description "מאמר מדעי" @default.
- Q91283841 description "مقالة علمية نشرت في 14 نوفمبر 2019" @default.
- Q91283841 description "১৪ নভেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q91283841 description "บทความทางวิทยาศาสตร์" @default.
- Q91283841 description "სამეცნიერო სტატია" @default.
- Q91283841 name "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 name "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 type Item @default.
- Q91283841 label "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 label "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 prefLabel "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 prefLabel "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.
- Q91283841 P1433 Q91283841-E3362A55-D854-492F-B6D1-13C1A00B5258 @default.
- Q91283841 P1476 Q91283841-CEDE3365-05F9-404B-BCA7-465547C7FE54 @default.
- Q91283841 P2093 Q91283841-204E8821-2D0F-451F-92CE-03BE003A038C @default.
- Q91283841 P2093 Q91283841-3E904B96-4886-43D5-92C7-6532AB81CEAE @default.
- Q91283841 P2093 Q91283841-5303FB02-5F82-4BD4-B2AF-4FF37C9BBD23 @default.
- Q91283841 P2093 Q91283841-5E97451C-BF4A-4810-8935-DF100AEB49A6 @default.
- Q91283841 P2093 Q91283841-71A484B6-D3B0-49DE-BCC2-ED5B80D32086 @default.
- Q91283841 P2093 Q91283841-77AD7B84-5A93-4D94-AA3F-74DB467E70AF @default.
- Q91283841 P2093 Q91283841-7CA0009E-02B3-44B6-9D40-6CA60B7A447D @default.
- Q91283841 P2093 Q91283841-7EA11AA3-25DB-4B27-8527-D1D62C5321BB @default.
- Q91283841 P2093 Q91283841-80A87D8C-F7D3-4C17-B94C-B38B17B9B1A0 @default.
- Q91283841 P2093 Q91283841-976665FD-D0A9-4749-A73E-A762759618DF @default.
- Q91283841 P2093 Q91283841-9E2D4D7C-1AA1-4317-846D-A43577CF1F3F @default.
- Q91283841 P2093 Q91283841-AA5AD436-9775-4A5C-BE9A-D7210D3F2FB7 @default.
- Q91283841 P2093 Q91283841-B41316DE-721E-4644-A4E3-898A394B4780 @default.
- Q91283841 P2093 Q91283841-BA54067B-E02C-4492-9E54-F021AB12831C @default.
- Q91283841 P2093 Q91283841-CD17DE76-7209-41DE-9D43-E0B2E71AE5F9 @default.
- Q91283841 P2093 Q91283841-E022F2AF-5EF5-4B03-B720-9F9338F074E9 @default.
- Q91283841 P304 Q91283841-31B59A52-59FD-441A-9C69-12C1779C0ABA @default.
- Q91283841 P31 Q91283841-6DCDAFDB-98E8-4B78-9ECA-41A374F3B888 @default.
- Q91283841 P356 Q91283841-8EECA32A-7EED-4CB2-813F-BDCCAE262646 @default.
- Q91283841 P433 Q91283841-8BDE64F9-E056-4B87-B16F-2C5C6E865778 @default.
- Q91283841 P478 Q91283841-8F7BB5D9-A342-475E-98C1-838E34C2039B @default.
- Q91283841 P50 Q91283841-3A1B4F61-2801-498C-8DCD-B7AAF1420079 @default.
- Q91283841 P50 Q91283841-BFE4BFC3-C353-42C7-AFCF-24457984E7B0 @default.
- Q91283841 P577 Q91283841-099A72C6-45EC-4B42-8945-02D0071E1723 @default.
- Q91283841 P698 Q91283841-260AA99B-A2CF-479B-8BD7-903BE283D026 @default.
- Q91283841 P921 Q91283841-2A09101E-81FF-4218-A46D-BABF16FB5326 @default.
- Q91283841 P921 Q91283841-B38D2B1B-0929-4415-92BF-A3AAC72675DC @default.
- Q91283841 P932 Q91283841-D3252B84-ED87-4328-A691-854D34D6B6D1 @default.
- Q91283841 P356 S12885-019-6273-1 @default.
- Q91283841 P698 31727024 @default.
- Q91283841 P1433 Q326300 @default.
- Q91283841 P1476 "PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma" @default.